Equities

Ethema Health Corp

GRST:PKC

Ethema Health Corp

Actions
  • Price (USD)0.0008
  • Today's Change0.00 / 0.00%
  • Shares traded6.22m
  • 1 Year change+60.00%
  • Beta2.5561
Data delayed at least 15 minutes, as of Sep 20 2024 16:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Ethema Health Corp grew revenues 10.87% from 4.82m to 5.34m while net income improved 374.67% from 247.88k to 1.18m.
Gross margin--
Net profit margin10.91%
Operating margin-27.19%
Return on assets7.10%
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2023, cash reserves at Ethema Health Corp fell by 72.19k. However, Cash Flow from Investing totalled 2.45m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 530.16k for operations while cash used for financing totalled 2.08m.
Cash flow per share0.0003
Price/Cash flow per share6.07
Book value per share-0.0022
Tangible book value per share-0.0024
More ▼

Balance sheet in USDView more

Ethema Health Corp has a Debt to Total Capital ratio of 730.45%.
Current ratio0.0404
Quick ratio--
Total debt/total equity--
Total debt/total capital7.30
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.